# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA2026858 | F | Agonist activity at human alpha7 nAChR expressed in GH4C1 cells by FLIPR assay | Homo sapiens | 23 | cell-based format | Scientific Literature | ||
2. | ALA2026859 | F | Agonist activity at human alpha7 nAChR expressed in GH4C1 cells by FLIPR assay relative to control | Homo sapiens | 24 | cell-based format | Scientific Literature | ||
3. | ALA2026860 | B | Displacement of [3H]Dofetilide from human ERG expressed in CHO-K1 cells by scintillation proximity assay | Homo sapiens | 23 | cell-based format | Scientific Literature | ||
4. | ALA2026861 | A | Intrinsic permeability of the compound in MDCK cells expressing MDR1 | Canis lupus familiaris | 10 | cell-based format | Scientific Literature | ||
5. | ALA2026862 | A | Efflux ratio of intrinsic permeability of the compound in MDCK cells expressing MDR1 | Canis lupus familiaris | 9 | cell-based format | Scientific Literature | ||
6. | ALA2026863 | A | Clearance in rat liver assessed per gram of tissue | Rattus norvegicus | 3 | tissue-based format | Scientific Literature | ||
7. | ALA2026864 | A | Clearance in human liver assessed per gram of tissue | Homo sapiens | 3 | tissue-based format | Scientific Literature | ||
8. | ALA2026865 | B | Inhibition of human ERG | Homo sapiens | 3 | single protein format | Scientific Literature | ||
9. | ALA2026866 | A | Blood clearance in Sprague-Dawley rat at 1 mg/kg, iv | Rattus norvegicus | 3 | organism-based format | Scientific Literature | ||
10. | ALA2026867 | A | Half life in Sprague-Dawley rat at 1 mg/kg, iv | Rattus norvegicus | 3 | organism-based format | Scientific Literature | ||
11. | ALA2026868 | A | Tmax in Sprague-Dawley rat at 3 mg/kg, po | Rattus norvegicus | 2 | organism-based format | Scientific Literature | ||
12. | ALA2026869 | A | Oral bioavailability in Sprague-Dawley rat at 3 mg/kg | Rattus norvegicus | 2 | organism-based format | Scientific Literature | ||
13. | ALA2026871 | A | Ratio of drug level in brain to blood in CD1 mouse at 5 mg/kg, po after 3 hrs | Mus musculus | 2 | organism-based format | Scientific Literature | ||
14. | ALA2026872 | A | Inhibition of CYP1A2 | 1 | single protein format | Scientific Literature | |||
15. | ALA2026873 | A | Inhibition of CYP2C9 | 1 | single protein format | Scientific Literature | |||
16. | ALA2026874 | A | Inhibition of CYP2C19 | 1 | single protein format | Scientific Literature | |||
17. | ALA2026875 | A | Inhibition of CYP2D6 | 1 | single protein format | Scientific Literature | |||
18. | ALA2026876 | A | Inhibition of CYP3A4 using diethoxyfluorescein as substrate | 1 | single protein format | Scientific Literature | |||
19. | ALA2026877 | A | Inhibition of CYP3A4 using 7-benzyloxyquinoline as substrate | 1 | single protein format | Scientific Literature | |||
20. | ALA2026878 | F | Antagonist activity at alpha1 nAChR | 1 | assay format | Scientific Literature |